767 related articles for article (PubMed ID: 26182253)
1. [Non-alcoholic fatty liver disease (NAFLD)].
Rau M; Weiss J; Geier A
Dtsch Med Wochenschr; 2015 Jul; 140(14):1051-5. PubMed ID: 26182253
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease as a multi-systemic disease.
Fotbolcu H; Zorlu E
World J Gastroenterol; 2016 Apr; 22(16):4079-90. PubMed ID: 27122660
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
Perumpail RB; Wong RJ; Ahmed A; Harrison SA
Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
5. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
Zhu C; Zhou D; Fan J
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471
[TBL] [Abstract][Full Text] [Related]
6. Study of Clinical Profile of Patients of Non Alcoholic Fatty Liver Disease and its Association with Metabolic Syndrome.
Gaharwar R; Trikha S; Margekar SL; Jatav OP; Ganga PD
J Assoc Physicians India; 2015 Jan; 63(1):12-6. PubMed ID: 26591121
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
[TBL] [Abstract][Full Text] [Related]
8. The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity.
Ampuero J; Aller R; Gallego-Durán R; Banales JM; Crespo J; García-Monzón C; Pareja MJ; Vilar-Gómez E; Caballería J; Escudero-García D; Gomez-Camarero J; Calleja JL; Latorre M; Albillos A; Salmeron J; Aspichueta P; Lo Iacono O; Francés R; Benlloch S; Fernández-Rodríguez C; García-Samaniego J; Estévez P; Andrade RJ; Turnes J; Romero-Gómez M;
Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1260-1270. PubMed ID: 30353552
[TBL] [Abstract][Full Text] [Related]
9. Comparison between a pediatric health promotion center and a pediatric obesity clinic in detecting metabolic syndrome and non-alcoholic fatty liver disease in children.
Yang HR; Yi DY; Choi HS
J Korean Med Sci; 2014 Dec; 29(12):1672-7. PubMed ID: 25469068
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
Qureshi K; Abrams GA
Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
Satapathy SK; Sanyal AJ
Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.
Athyros VG; Tziomalos K; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP
World J Gastroenterol; 2015 Jun; 21(22):6820-34. PubMed ID: 26078558
[TBL] [Abstract][Full Text] [Related]
13. Managing non-alcoholic fatty liver disease.
Ngu JH; Goh GB; Poh Z; Soetikno R
Singapore Med J; 2016 Jul; 57(7):368-71. PubMed ID: 27439352
[TBL] [Abstract][Full Text] [Related]
14. Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka.
Perera N; Indrakumar J; Abeysinghe WV; Fernando V; Samaraweera WM; Lawrence JS
BMC Cardiovasc Disord; 2016 Feb; 16():37. PubMed ID: 26869052
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
Roeb E; Geier A
Z Gastroenterol; 2019 Apr; 57(4):508-517. PubMed ID: 30965381
[TBL] [Abstract][Full Text] [Related]
16. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H
J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.
Boyraz M; Hatipoğlu N; Sarı E; Akçay A; Taşkın N; Ulucan K; Akçay T
Obes Res Clin Pract; 2014; 8(4):e356-63. PubMed ID: 25091357
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease - A multisystem disease?
Mikolasevic I; Milic S; Turk Wensveen T; Grgic I; Jakopcic I; Stimac D; Wensveen F; Orlic L
World J Gastroenterol; 2016 Nov; 22(43):9488-9505. PubMed ID: 27920470
[TBL] [Abstract][Full Text] [Related]
19. Modern approach to the clinical management of non-alcoholic fatty liver disease.
Del Ben M; Polimeni L; Baratta F; Pastori D; Loffredo L; Angelico F
World J Gastroenterol; 2014 Jul; 20(26):8341-50. PubMed ID: 25024593
[TBL] [Abstract][Full Text] [Related]
20. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]